Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.12.2011 | Review

Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway

verfasst von: W. Berger, A. Pircher, M. Sibilia, L. Bubendorf, M. Filipits, M. Fiegl, M. Früh, C. Manegold, H. Popper, W. Hilbe

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Gender and oncology: Pathological observations

Nächster Artikel A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*

Titel: Molecular oncology in lung cancer – between biomarkers and clinical application. Relevance of the Ras–Raf–MEK–ERK pathway
verfasst von: W. Berger
A. Pircher
M. Sibilia
L. Bubendorf
M. Filipits
M. Fiegl
M. Früh
C. Manegold
H. Popper
W. Hilbe
Publikationsdatum: 01.12.2011
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2011
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-011-0281-4

Weitere Artikel der Ausgabe 4/2011

Cancer in the elderly and gender aspects – situation in Tyrol

Short review

Gender differences in quality of life in patients with haematological malignancies

Short review

Treatment of invasive aspergillosis in cancer patients

Short review

Gender and haemato-oncology: Aspects of pharmacokinetics and pharmacodynamics

Short review

Gender aspects in haematology and oncology: Overview and own observations in lung cancer

Leading article

Gender aspects in tumours of the nervous system

Short review